Medline (MDLN) Long-Term Deferred Tax (2025 - 2026)

Medline (MDLN) posted quarterly Long-Term Deferred Tax of $837.0 million for Q1 2026, up 43.57% quarter-over-quarter from $583.0 million in Q4 2025.

Medline (MDLN) Long-Term Deferred Tax (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Long-Term Deferred Tax for 2 consecutive years, with $837.0 million the latest figure, recorded in Q1 2026.

In Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $837.0 million; the TTM figure through Mar 2026 stood at $837.0 million (changed N/A YoY), while the FY2025 annual figure was $583.0 million, changed N/A from the prior year.
Long-Term Deferred Tax rose to $837.0 million in Q1 2026 per MDLN's latest filing, from $583.0 million in the prior quarter.
Across five years, Long-Term Deferred Tax topped out at $837.0 million in Q1 2026 and bottomed at $583.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn
10	Align Technology	11.61 Bn	10.51 Bn	757.43 Mn

Download Data